Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.55	-767.24	755.57
Graham Fair Price	14.94	1.45	1.26
PEG	3.59	0.11	-0.11
Price/Book	16.25	0.34	0.29
Price/Cash Flow	35.28	1.23	-0.91
Prices/Earnings	-7.01	3.12	3.35
Price/Sales	-42.90	4.04	-7.08
Price/FCF	35.28	1.23	-0.91
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-26.07	0.44	-0.60
ROA	39.95	< 0.005	< 0.005
ROE	0.02	0.03	25.01
ROIC	< 0.005	0.02	363.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.87	4.86	-82.12
Dividends QOQ	-0.32	-0.62	-96.24
EBIT QOQ	-0.41	0.55	34.55
EPS QOQ	-0.32	0.29	-10.23
FCF QOQ	-4.51	1.88	-58.20
Revenue QOQ	-1.29	3.09	139.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	-4.22	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.77	0.30	-60.68
Quick Ratio	8.61	37.70	337.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.80	1.85	2.80
Cash	0.48	0.50	4.07
Capex	-0.02	< 0.005	82.48
Free Cash Flow	-0.58	0.51	-11.66
Revenue	-0.07	0.16	109.28
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	8.55	37.70	341.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	691.50	-255.15	-63.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating